Search references for BOCOCIZUMAB. Phrases containing BOCOCIZUMAB
See searches and references containing BOCOCIZUMAB!BOCOCIZUMAB
Chemical compound
Bococizumab (USAN; development code RN316) is a drug that was in development by Pfizer targeting PCSK9 to reduce LDL cholesterol. Pfizer withdrew the
Bococizumab
Monoclonal antibody against amyloid beta
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Donanemab
Antibodies from clones of the same blood cell
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Monoclonal_antibody
Mammalian protein found in humans
clinical trials as of 2014[update]. These include evolocumab (Amgen), bococizumab (Pfizer), and alirocumab (Sanofi/Regeneron Pharmaceuticals). As of July 2015[update]
PCSK9
Antibodies from non-human species made nearly identical with human ones
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Humanized_antibody
Drug class
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Anti-amyloid_antibodies
Pharmaceutical drug
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Evolocumab
Chemical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Bimagrumab
Monoclonal antibody against amyloid beta
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Lecanemab
Biotechnology company
against calcitonin gene-related peptide for the treatment of migraines Bococizumab (codenamed RN316), a monoclonal antibody against PCSK9 designed to reduce
Rinat Neuroscience Corporation
Rinat_Neuroscience_Corporation
Human monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Denosumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Emicizumab
Experimental monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Prasinezumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Etaracizumab
Medication
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Bevacizumab
High levels of cholesterol in the blood
women. Injectable antibodies against the protein PCSK9 (evolocumab, bococizumab, alirocumab) can reduce LDL cholesterol and have been shown to reduce
High_cholesterol
Pharmaceutical biological monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Fremanezumab
Pharmaceutical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Abciximab
Pharmaceutical drug
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Romosozumab
Medication
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Marstacimab
Chemical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Caplacizumab
Medication
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Concizumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Stamulumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Bedinvetmab
Blontress mab veterinary CD20 Blosozumab mab humanized SOST osteoporosis Bococizumab mab humanized PCSK9 dyslipidemia Brazikumab mab human IL-23 Crohn's disease
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Pharmaceutical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Indium_(111In)_imciromab
Chemical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Bapineuzumab
Monoclonal antibody medication
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Solanezumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Trevogrumab
Canadian cardiologist
Yunis C, Shear Cl, Tardif JC. Cardiovascular efficacy and safety of bococizumab in high risk patients. N Engl J Med 2017;376:1527-1539. In these large
Jean-Claude_Tardif
Drugs that inhibit α-synuclein
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Anti-α-synuclein_drug
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Galcanezumab
Medication
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Idarucizumab
Monoclonal antibody protein
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Gantenerumab
Monoclonal antibody designed to treat X-linked hypophosphatemia
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Burosumab
Monoclonal antibody against amyloid beta
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Aducanumab
Veterinary medication
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Izenivetmab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Abelacimab
Pharmaceutical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Amlenetug
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Inclacumab
Veterinary medication
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Relfovetmab
Pharmaceutical drug
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Alirocumab
Chemical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Erenumab
Antibody tested against Alzheimer's
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Crenezumab
Anti-tau monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Semorinemab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Eptinezumab
Pharmaceutical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Devextinetug
Medication for macular degeneration
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Faricimab
Chemical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Tanezumab
Pharmaceutical drug
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Brolucizumab
Pharmaceutical drug
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Ramucirumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Evinacumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Demcizumab
Medication
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Bentracimab
Experimental monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Cinpanemab
Chemical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Blosozumab
Pharmaceutical drug
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Ranibizumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Ozanezumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Enoticumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Rinucumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Opicinumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Vanucizumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Fasinumab
Chemical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Fulranumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Icrucumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Orticumab
Pharmaceutical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Indium_(111In)_biciromab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Refanezumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Ralpancizumab
Chemical compound
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Ascrinvacumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Ponezumab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Volociximab
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Nesvacumab
Pharmaceutical drug
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Alacizumab_pegol
Monoclonal antibody
Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab Demcizumab Emicizumab Etaracizumab
Tadocizumab
BOCOCIZUMAB
BOCOCIZUMAB
BOCOCIZUMAB
BOCOCIZUMAB
Boy/Male
Tamil
Indrarjun | இநà¯à®¤à¯à®°à®¾à®°à¯à®œà¯à®¨
Bright and brave Indra
Girl/Female
American, Australian, British, Christian, Dutch, English, French, German, Greek, Latin, Swiss
Victory of the People; Necklace; Victorious; Variant of Nicolette
Boy/Male
Tamil
Twilight, Evening, Close of the day
Girl/Female
Indian
Slave of Allah
Girl/Female
Tamil
Pranisha | பà¯à®°à®¨à¯€à®·à®¾
Love to life
Boy/Male
Bengali, Indian
The God
Girl/Female
Hindu
Understood
Boy/Male
Tamil
Amrutheswar | அமரதேஸà¯à®µà®°
Name of Lord Shiva
Girl/Female
Muslim/Islamic
Polite obedience
Boy/Male
Hindu, Indian, Tamil
God's Name
BOCOCIZUMAB
BOCOCIZUMAB
BOCOCIZUMAB
BOCOCIZUMAB
BOCOCIZUMAB